Primary Care Intervention for PTSD in Ethiopia
Posttraumatic Stress Disorder Intervention for People With Severe Mental Illness in Low- and Middle-Income Country Primary Care Settings
1 other identifier
interventional
14
1 country
1
Brief Summary
Mixed methods (qualitative and quantitative) cluster randomized pilot feasibility trial (n=40) to refine the the Brief Relaxation, Education and Trauma Healing (BREATHE) Ethiopia intervention and explore effectiveness and implementation. Fifty patients will be enrolled across the pre-pilot and the pilot to account for potential treatment dropout. Eight health care centers will be randomized to Treatment or Waitlist conditions.
- 1.Primary outcomes: Change in hypothesized treatment mechanisms: (1) increased knowledge about PTSD; reductions in (2) PTSD-related stigma; (3) trauma-related cognitions; and (4) self-reported arousal; (5) increased use of stress management strategies; and (6) reductions in physiological arousal as measured by increased heart rate variability.
- 2.Secondary outcomes: Change in symptoms and functional impairment. Reductions in (1) PTSD (2) depression and anxiety symptoms, and (3) functional impairment.
- 3.Process evaluation: Mixed methods multi-stakeholder process evaluation of the implementation of the intervention as measured by the RE-AIM framework (Reach, Effectiveness, Adoption, Implementation, Maintenance). We will collect qualitative data on Adoption and Implementation (e.g. facilitators and barriers to intervention delivery) and quantitative assessment of patient and provider participation and retention (Reach), satisfaction (Adoption) and fidelity (Implementation).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 28, 2020
CompletedFirst Posted
Study publicly available on registry
May 13, 2020
CompletedStudy Start
First participant enrolled
June 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 20, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 20, 2023
CompletedAugust 6, 2025
August 1, 2025
5 months
April 28, 2020
August 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Change in PTSD Knowledge
Changes in levels of PTSD Knowledge measured by the PTSD Knowledge Test (0-14, higher scores indicating more PTSD knowledge).
Day 0 baseline, 3 months
Change in PTSD Related Stigma
Changes in levels of PTSD Related Stigma measured by The Internalized Stigma of Mental Illness Scale (1 minimal stigma to 4 severe internalized stigma).
Day 0 baseline, 3 months
Change in Trauma-related cognitions
Changes in levels of trauma-related cognitions assessed by the Post-Traumatic Cognitions Inventory (36-252 higher scores indicating higher incidence of negative trauma related cognitions).
Day 0 baseline, 3 months
Change in Self-reported arousal
Changes in self-reported arousal levels measured with Self-Assessment Manikin (Self-Assessment Manikin measures arousal using 3 subscales: Valence, 1 unpleasant to 5 pleasant; Arousal rating, 1 calm to 5 excited; and Dominance, 1 independent to 5 dependent).
Day 0 baseline, 3 months
Change in Stress management strategy use
Changes in use of the breathing retraining techniques as measured by self- and caregiver-reports during in-session homework review.
Day 0 baseline, 3 months
Change in Physiological arousal
Changes in physiological arousal levels measured by heart rate variability (HRV).
Day 0 baseline, 3 months
Secondary Outcomes (4)
Change in PTSD Symptoms
Day 0 baseline, 3 months
Change in Depression Symptoms
Day 0 baseline, 3 months
Change in Anxiety Symptoms
Day 0 baseline, 3 months
Change in Functional impairment
Day 0 baseline, 3 months
Study Arms (2)
BREATHE Intervention
EXPERIMENTALFive session program, with additional sessions provided based on the individual's learning style and needs. Sessions are designed to be 20 to 30 minutes long, to accommodate the needs of the primary health care centers. Sessions will ideally be conducted once per week, but may be conducted as infrequently as once per month.
Waitlist Treatment as Usual
ACTIVE COMPARATORTypical primary care treatment which will include medication management and follow-up at the health facilities, at at least the same frequency as treatment arm. At the End of the trial participants will be able to receive the BREATHE Ethiopia PTSD treatment
Interventions
5 session program focusing on breathing retraining, psychoeducation, and positive coping.
Typical primary care treatment which will include medication management and follow-up at the health facilities, at at least the same frequency as treatment arm. At the end of the trial Participants will be able to receive the BREATHE Ethiopia treatment.
Eligibility Criteria
You may qualify if:
- For all participants: Being 18 years of age or older
- For all participants: Being able and willing to provide informed consent to participate in the study
- For all participants: Being able to complete procedures in Amharic or English.
- For patients: Treatment at a Sodo district primary care clinic for Severe Mental Illness (SMI)
- For patients: Identified as having:
- Experienced a traumatic event,
- Associated PTSD symptoms defined as scores on the PTSD Checklist DSM-5 (PCL-5), AND
- any associated functional impairment on the WHODAS-2.
- For health care providers: Providers working at the target health centers who administer, provider care for, or supervise the care of patients with mental health concerns.
- For caregivers: Being identified by the patient as a close family member or friend whom the patient gives permission to be involved in the study
You may not qualify if:
- Current high risk of suicide as measured by the Composite International Diagnostic Interview (CIDI) Suicide module
- Inability to participate in the treatment, as determined by the psychiatric nurse.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of California, Los Angeleslead
- Addis Ababa Universitycollaborator
Study Sites (1)
Addis Ababa University
Addis Ababa, Ethiopia
Related Publications (1)
Ng LC, Serba EG, Dubale BW, Fekadu A, Hanlon C. Posttraumatic stress disorder intervention for people with severe mental illness in a low-income country primary care setting: a randomized feasibility trial protocol. Pilot Feasibility Stud. 2021 Jul 30;7(1):149. doi: 10.1186/s40814-021-00883-3.
PMID: 34330334DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 28, 2020
First Posted
May 13, 2020
Study Start
June 1, 2023
Primary Completion
October 20, 2023
Study Completion
October 20, 2023
Last Updated
August 6, 2025
Record last verified: 2025-08